Portal Instruments, Inc.

CAMBRIDGE, MA · Founded 2012 · Medtech · Private

PRIME platform for rapid subcutaneous delivery of high-viscosity biologics

Claim this profile

Follows are private to you and power your alerts

Updated · portalinstruments.com

Sector
Medtech
Headquarters
CAMBRIDGE, MA
Founded
2012
Latest Form D
$7M, Apr 2022
Total capital
$28.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$28.5M
4 Form D · last Apr 2022
54 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
32
8 pending · first 2019
Rank in peer group#59 of 1112

Capital timeline

20142016201820202022FEDERAL ↑EQUITY ↓Cumulative $28.5M1st Form D$5.5M2nd Form D$10M3rd Form D$6M4th Form D$7M
20142016201820202022FEDERAL ↑EQUITY ↓Cumulative $28.5M3rd Form D$6M4th Form D$7M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$7M
  • Private capital raisedForm D · SEC · 3rd filing$6M
  • Private capital raisedForm D · SEC · 2nd filing$10M
  • Private capital raisedForm D · SEC · 1st filing$5.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#59 · top 5%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Bruce ClarkeDirectorNamed in SEC Form D filings
  • Dr. Ian W. HunterExecutive Officer, DirectorNamed in SEC Form D filings
  • Dr. James A. YoungDirectorNamed in SEC Form D filings
  • Dr. Katherine A. BowdishDirectorNamed in SEC Form D filings
  • Dr. Patrick A. AnquetilExecutive Officer, DirectorNamed in SEC Form D filings
  • Ian HunterExecutive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
  • Jim A. YoungDirectorNamed in SEC Form D filings
  • Katherine A. BowdishDirectorNamed in SEC Form D filings
  • Patrick AnquetilExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 32 granted of 40
  • PendingRotary Motor Based Transdermal Injection DeviceUSPTOApplication 19253228
  • GrantedEncoding Information For Drug DeliveryUSPTOUS 12,465,689
  • PendingActive Injection GuideUSPTOApplication 19184191
Show all 40 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .